COVINNOVATIONS

Owner

Goods & Services

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious disease, including COVID-19; Medical diagnostic reagents and assays for testing body fluids for microorganisms relating to infectious disease, including COVID-19; Medical diagnostic reagents and assays for testing of body fluids relating to infectious disease, including COVID-19; Therapeutic pharmaceutical for the treatment of infectious disease, including COVID-19; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids relating to infectious disease, including COVID-19; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of infectious disease, including COVID-19

Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing of infectious disease, including COVID-19; Medical diagnostic apparatus for testing DNA and RNA samples for infectious disease, including COVID-19; Medical diagnostic apparatus for testing for viruses, including COVID-19; Medical diagnostic apparatus for testing DNA and RNA samples for infectious disease, including COVID-19; Medical diagnostic apparatus for testing of nucleic acids for infectious disease, including COVID-19

Research and development and consultation related thereto in the field of infectious disease, including COVID-19 testing; Research and development in the field of infectious disease, including COVID-19 testing; Research and development in the pharmaceutical and biotechnology fields, relating to infectious disease, including COVID-19; Research and development of technology in the field of infectious disease, including COVID-19 testing; Research and development services in the field of antibodies relating to infectious disease, including COVID-19; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines relating to infectious disease, including COVID-19; Scientific research and development relating to infectious disease, including COVID-19; Pharmaceutical research and development relating to infectious disease, including COVID-19

Medical diagnostic testing, monitoring and reporting services relating to infectious disease, including COVID-19; Medical services, namely, the treatment of infectious disease through the use of diagnostic testing to determine key susceptibilities to identified viruses, including COVID-19, and a course of therapeutics and pharmaceutical preparations in accordance with said susceptibilities; Medical testing for diagnostic or treatment purposes relating to infectious disease, including COVID-19; Medical testing for diagnostic or treatment purposes in the field of infectious disease, including COVID-19